Crispr-Cas13 System As A Promising And Versatile Tool For Cancer Diagnosis, Therapy, And Research
Autor: | Ayça Nur Demir, Mehmet Ozsoz, Abdullah Tozluyurt, Ali Kerem Kalkan, Ozgur Can, Fahreddin Palaz, Ahsen Özcan |
---|---|
Rok vydání: | 2021 |
Předmět: |
0106 biological sciences
Diagnostic methods Biomedical Engineering Cancer therapy Early detection Computational biology 01 natural sciences Biochemistry Genetics and Molecular Biology (miscellaneous) 03 medical and health sciences 010608 biotechnology Neoplasms medicine CRISPR Humans Molecular Targeted Therapy Liquid biopsy Precision Medicine Early Detection of Cancer 030304 developmental biology Gene Editing 0303 health sciences business.industry Genome Human Liquid Biopsy Cancer General Medicine medicine.disease Molecular analysis Cancer treatment RNA CRISPR-Cas Systems business Transcriptome |
Popis: | Over the past decades, significant progress has been made in targeted cancer therapy. In precision oncology, molecular profiling of cancer patients enables the use of targeted cancer therapeutics. However, current diagnostic methods for molecular analysis of cancer are costly and require sophisticated equipment. Moreover, targeted cancer therapeutics such as monoclonal antibodies and small-molecule drugs may cause off-target effects and they are available for only a minority of cancer driver proteins. Therefore, there is still a need for versatile, efficient, and precise tools for cancer diagnostics and targeted cancer treatment. In recent years, the CRISPR-based genome and transcriptome engineering toolbox has expanded rapidly. Particularly, the RNA-targeting CRISPR-Cas13 system has unique biochemical properties, making Cas13 a promising tool for cancer diagnosis, therapy, and research. Cas13-based diagnostic methods allow early detection and monitoring of cancer markers from liquid biopsy samples without the need for complex instrumentation. In addition, Cas13 can be used for targeted cancer therapy through degrading and manipulating cancer-associated transcripts with high efficiency and specificity. Moreover, Cas13-mediated programmable RNA manipulation tools offer invaluable opportunities for cancer research, identification of drug-resistance mechanisms, and discovery of novel therapeutic targets. Here, we review and discuss the current use and potential applications of the CRISPR-Cas13 system in cancer diagnosis, therapy, and research. Thus, researchers will gain a deep understanding of CRISPR-Cas13 technologies, which have the potential to be used as next-generation cancer diagnostics and therapeutics. |
Databáze: | OpenAIRE |
Externí odkaz: |